top of page

Neuroshine Clinical Governance Framework

Effective Date: [Insert Date]
Last Updated: [Insert Date]

1. Purpose

The purpose of this framework is to ensure that Neuroshine delivers safe, effective, high-quality ADHD care in line with UK regulatory requirements, including:

  • Care Quality Commission (CQC) standards

  • General Medical Council (GMC) guidance

  • Nursing and Midwifery Council (NMC) standards

  • National Institute for Health and Care Excellence (NICE) ADHD guidelines (NG87)

  • Data protection and safeguarding legislation

2. Scope

  • This framework applies to:

  • All Neuroshine clinicians (doctors, nurse prescribers, allied professionals)

  • Administrative and support staff

  • Clients accessing ADHD assessments, prescriptions, and ongoing treatment

3. Core Principles

Neuroshine’s clinical governance is built around six domains:

  1. Clinical Effectiveness – Providing evidence-based ADHD care aligned with NICE guidance.

  2. Patient Safety – Minimising risks through safe prescribing, safeguarding, and monitoring.

  3. Risk Management – Identifying, reporting, and mitigating risks.

  4. Audit & Quality Improvement – Continuous review of services and prescribing practices.

  5. Patient Experience & Involvement – Ensuring feedback informs service design.

  6. Staff Development & Accountability – Training, appraisal, and professional standards.

4. Clinical Leadership & Accountability

  • Medical Director / Lead Prescriber – Responsible for clinical safety, prescribing oversight, and governance.

  • Safeguarding Lead – Ensures compliance with child and adult safeguarding duties.

  • Data Protection Officer (DPO) – Oversees GDPR compliance and confidentiality.

  • Clinical Governance Committee – Meets quarterly to review risks, incidents, complaints, and audits.

5. Policies & Procedures

Neuroshine operates under the following key clinical governance policies:

  • Medication Policy (safe prescribing, monitoring, controlled drugs compliance)

  • Safeguarding Policy (children & adults at risk)

  • Data Protection & Confidentiality Policy

  • Complaints Policy

All policies are reviewed annually or sooner where legislation changes.

6. Prescribing & Medicines Management

  • Prescribers follow GMC Good Practice in Prescribing (2021).

  • Shared care protocols with GPs are used where appropriate.

  • Controlled drug prescribing complies with Misuse of Drugs Regulations 2001.

  • Medication audits are carried out quarterly to review prescribing safety and appropriateness.

7. Risk Management

  • Incident Reporting: All clinical incidents, near-misses, or errors are logged, investigated, and reviewed.

  • Safeguarding Escalation: Immediate referral to safeguarding authorities when risk of harm is identified.

  • Business Continuity: Plans in place for IT failures, data breaches, or clinician unavailability.

8. Patient Involvement

  • Patients are provided with clear information about treatment, risks, and alternatives.

  • Informed consent is obtained for all assessments and prescriptions.

  • Feedback is collected via surveys and complaints procedures and reviewed quarterly.

9. Audit & Continuous Improvement

  • Clinical audits: Prescribing reviews, record-keeping checks, safeguarding compliance.

  • Quality improvement: Action plans implemented after audits.

  • Annual report: Summarises governance performance, complaints, audits, and outcomes.

10. Staff Training & Development

  • All staff receive mandatory training: safeguarding, data protection, confidentiality, clinical risk management.

  • Prescribers maintain CPD and revalidation with GMC/NMC.

  • Appraisals carried out annually with performance reviews against governance standards.

11. Information Governance

  • Compliance with UK GDPR & Data Protection Act 2018.

  • Patient records stored securely using encrypted systems.

  • Access limited to authorised staff only.

  • Data breaches reported to the ICO as required.

12. Review

This framework will be reviewed annually by the Clinical Governance Committee and updated in line with:

  • New NICE guidance

  • CQC recommendations

  • Feedback from audits, patients, or staff

13. Contact

Neuroshine Clinical Governance Team
Email: support@neuroshine.co.uk
Phone: [Insert UK Number]

bottom of page